Estrogen directly acts on osteoclasts via inhibition of inward rectifier K+ channels

Naunyn Schmiedebergs Arch Pharmacol. 2000 Jun;361(6):610-20. doi: 10.1007/s002100000243.

Abstract

Using the whole-cell patch-clamp technique in freshly isolated rat osteoclasts we examined the effects of estrogen on ionic channels. The predominant current was an inward rectifier K+ current (IKir). In the absence of non-osteoclastic cells, extracellularly applied 17beta-estradiol (>0.1 microM) inhibited IKir, indicating that estrogen acts directly on osteoclasts. Application of 17beta-estradiol (10 microM) for 10 min reduced IKir at the membrane potential of -120 mV to 70 +/- 15% of control. Removal of 17beta-estradiol partially restored the inhibition. The inhibition of IKir was dependent on concentration and application time. Intracellularly applied 17beta-estradiol had no effect on IKir. 17alpha-estradiol also inhibited the IKir, whereas progesterone and testosterone had no effect. The inhibitory action of 17beta-estradiol was not affected by guanosine 5'-O-(2-thiodiphosphate) (GDPbetaS), adenosine 3',5'-cyclic monophosphothioate Rp diastereomer (Rp-cAMPS), okadaic acid, staurosporine and phorbol ester, and was independent of intracellular Ca2+ concentration ([Ca2+]i). With no influence from soluble factors secreted from non-osteoclastic cells, preincubation of the osteoclasts for more than 60 min with much lower concentrations of 17beta-estradiol (1 and 10 nM) caused a reduction of IKir. In current-clamp configuration, application of 17beta-estradiol (10 microM) depolarized the membrane associated with a decrease in a membrane conductance, indicating that 17beta-estradiol inhibits IKir and depolarizes the membrane of osteoclasts. These results suggest that the 17beta-estradiol-induced inhibition of IKir might be mediated via non-genomic mechanisms. This direct action of 17beta-estradiol on osteoclasts may contribute to the regulation of [Ca2+]i and partially account for the protective effects of estrogen against bone loss.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Barium / metabolism
  • Calcium / metabolism
  • Cells, Cultured
  • Chelating Agents / pharmacology
  • Cyclic AMP / analogs & derivatives*
  • Cyclic AMP / pharmacology
  • Dose-Response Relationship, Drug
  • Estradiol / pharmacology*
  • Guanosine Diphosphate / analogs & derivatives*
  • Guanosine Diphosphate / pharmacology
  • Membrane Potentials / drug effects
  • Okadaic Acid / pharmacology
  • Osteoclasts / drug effects*
  • Osteoclasts / metabolism
  • Patch-Clamp Techniques
  • Potassium Channel Blockers*
  • Potassium Channels / metabolism
  • Potassium Channels, Inwardly Rectifying*
  • Progesterone / pharmacology
  • Rats
  • Rats, Wistar
  • Staurosporine / pharmacology
  • Testosterone / pharmacology
  • Tetradecanoylphorbol Acetate / pharmacology
  • Thionucleotides / pharmacology
  • Time Factors

Substances

  • Chelating Agents
  • Potassium Channel Blockers
  • Potassium Channels
  • Potassium Channels, Inwardly Rectifying
  • Thionucleotides
  • Guanosine Diphosphate
  • Okadaic Acid
  • adenosine-3',5'-cyclic phosphorothioate
  • Barium
  • Testosterone
  • Progesterone
  • Estradiol
  • guanosine 5'-O-(2-thiodiphosphate)
  • Cyclic AMP
  • Staurosporine
  • Tetradecanoylphorbol Acetate
  • Calcium